NF-κB-IN-18

NF-κB-IN-18 (Compound 5k) is an orally bioavailable inhibitor that targets the NF-κB pathway by suppressing p65 phosphorylation. It exhibits potent anti-inflammatory effects in vivo, as demonstrated in a murine model of xylene-induced ear edema, supporting its use in inflammation-related research.